Addicort (Oxytetracycline + Triamcinolone Acetonide)
Topical corticosteroid-antibiotic combination cream for infected inflammatory skin conditions
Addicort is a prescription topical cream combining oxytetracycline (a tetracycline antibiotic) with triamcinolone acetonide (a moderate-potency corticosteroid). It is used to treat inflammatory skin conditions where bacterial infection is present or suspected, such as infected eczema, infected dermatitis, and infected insect bites. The cream works by simultaneously reducing inflammation, itching, and redness while fighting bacterial infection at the skin surface.
Quick Facts
Key Takeaways
- Addicort is a combination cream containing oxytetracycline (antibiotic) and triamcinolone acetonide (corticosteroid), designed for inflammatory skin conditions with suspected or confirmed bacterial infection.
- Apply a thin layer to the affected area 2–3 times daily; treatment should generally not exceed 7–14 days to avoid adverse effects such as skin atrophy.
- Do not use Addicort on viral skin infections (e.g., herpes, chickenpox), fungal infections, rosacea, perioral dermatitis, or acne vulgaris.
- Avoid prolonged use on the face, groin, or armpits as these thin-skinned areas are particularly vulnerable to corticosteroid-induced skin thinning and stretch marks.
- Consult your doctor if symptoms do not improve within 7 days or if new symptoms develop during treatment – an alternative approach may be needed.
What Is Addicort and What Is It Used For?
Addicort belongs to a therapeutic class of combination products that provide both anti-inflammatory and antibacterial effects in a single topical formulation. This dual-action approach is particularly useful when healthcare providers determine that a patient's skin condition involves both an inflammatory component (such as eczema or dermatitis) and a bacterial infection that may be contributing to the severity of symptoms or delaying healing.
The corticosteroid component, triamcinolone acetonide, is classified as a moderate-potency topical corticosteroid according to international potency ranking systems. It works by suppressing the local immune response, reducing the release of pro-inflammatory cytokines and mediators, and decreasing capillary permeability. This results in reduced redness, swelling, itching, and discomfort in the affected area. Triamcinolone acetonide has been widely used in dermatology since the 1960s and has an extensive evidence base supporting its efficacy and safety when used appropriately.
The antibiotic component, oxytetracycline hydrochloride, is a member of the tetracycline class of broad-spectrum antibiotics. When applied topically, it inhibits the growth of susceptible bacteria by binding to the 30S ribosomal subunit and preventing the incorporation of amino acid residues into growing peptide chains. This effectively stops bacterial protein synthesis. Oxytetracycline is active against many gram-positive and gram-negative organisms commonly found in secondary skin infections, including Staphylococcus aureus and Streptococcus pyogenes.
Common Indications
Addicort cream is typically prescribed for the following conditions:
- Infected eczema (atopic dermatitis) – When atopic eczema becomes secondarily infected with bacteria, typically S. aureus, the combination of anti-inflammatory and antibiotic action helps clear the infection while controlling the underlying eczema flare.
- Infected contact dermatitis – Allergic or irritant contact dermatitis that has become superinfected due to scratching or skin barrier disruption.
- Infected insect bites and stings – Insect bite reactions that have become infected, particularly when there is significant inflammatory response alongside bacterial colonization.
- Infected intertrigo – Skin fold infections where both inflammation and bacterial overgrowth are present, though use should be limited in duration.
- Other infected dermatoses – Various inflammatory skin conditions complicated by secondary bacterial infection, where a prescriber determines that combined therapy is appropriate.
It is important to note that Addicort is not appropriate for all skin infections. Pure bacterial skin infections without an inflammatory component (such as impetigo) are better treated with antibiotics alone. Similarly, inflammatory skin conditions without evidence of infection should be treated with corticosteroids alone, avoiding unnecessary antibiotic exposure that could contribute to antimicrobial resistance.
What Should You Know Before Using Addicort?
Before starting treatment with Addicort, it is essential that your healthcare provider has a complete picture of your medical history, current medications, and any allergies. This information helps ensure that Addicort is the right choice for your specific condition and minimizes the risk of adverse effects or complications.
Contraindications
Addicort must not be used if you have any of the following conditions:
- Hypersensitivity to oxytetracycline, triamcinolone acetonide, other tetracyclines, other corticosteroids, or any of the excipients in the formulation.
- Viral skin infections – including herpes simplex (cold sores), varicella (chickenpox), and herpes zoster (shingles). Corticosteroids can suppress local immune defenses and allow viral replication to accelerate, potentially worsening the infection significantly.
- Fungal skin infections – such as tinea (ringworm), candidiasis, or other dermatomycoses. The corticosteroid component can mask the symptoms of fungal infections while allowing them to spread, a condition sometimes called tinea incognito.
- Tuberculosis of the skin – Corticosteroids can exacerbate cutaneous tuberculosis.
- Rosacea and perioral dermatitis – Topical corticosteroids are known to worsen these conditions and can cause a rebound effect upon discontinuation.
- Acne vulgaris – Corticosteroids can aggravate acne and are not appropriate treatment for this condition.
- Skin ulcers and open wounds – Application to broken skin increases systemic absorption and delays wound healing.
Never apply Addicort to the eyes or immediately surrounding eye area. Prolonged periocular use of topical corticosteroids can cause glaucoma, cataracts, and other serious eye complications. If accidental contact occurs, rinse thoroughly with water and seek medical advice.
Warnings and Precautions
Exercise particular caution in the following situations:
- Thin-skinned areas – The face, neck, groin, axillae (armpits), and skin folds are more susceptible to corticosteroid side effects. Use on these areas should be limited to the shortest duration necessary.
- Large surface areas – Applying Addicort to extensive areas of skin increases the risk of systemic absorption of both the corticosteroid and antibiotic components.
- Occlusive dressings – Covering the treated area with airtight bandages significantly increases corticosteroid absorption and the risk of systemic effects. Do not use occlusive dressings unless specifically directed by your physician.
- Prolonged use – Extended application beyond the recommended treatment duration increases the risk of skin atrophy, striae (stretch marks), telangiectasia (visible blood vessels), purpura (bruising), and adrenal suppression.
- Secondary infection – If the infection does not improve or worsens during treatment, discontinue Addicort and consult your healthcare provider, as the infecting organism may be resistant to oxytetracycline.
- Antimicrobial resistance – Overuse or inappropriate use of topical antibiotics, including oxytetracycline, contributes to the development of bacterial resistance. This is a global public health concern highlighted by the WHO.
Pregnancy and Breastfeeding
The use of Addicort during pregnancy requires careful consideration of the potential risks and benefits. Topical corticosteroids should be used during pregnancy only when clearly necessary and under medical supervision. While systemic absorption from topical application is typically low, animal studies with triamcinolone acetonide have demonstrated adverse developmental effects at high doses, including cleft palate and intrauterine growth retardation.
The oxytetracycline component presents additional considerations. The tetracycline class of antibiotics is generally contraindicated during the second and third trimesters of pregnancy due to potential effects on fetal bone and tooth development (permanent discoloration of teeth). However, the amount of oxytetracycline absorbed systemically from topical application is typically minimal. Despite this, the precautionary principle applies, and alternative treatments should be considered during pregnancy.
If you are breastfeeding, discuss the use of Addicort with your healthcare provider. Both corticosteroids and tetracyclines can pass into breast milk in small amounts. If treatment is deemed necessary, avoid applying Addicort to the breast area to prevent direct infant exposure.
Use in Children
Children are more susceptible to the systemic effects of topical corticosteroids due to their higher skin surface area-to-body weight ratio. Use of Addicort in children should be limited to the minimum effective dose for the shortest duration possible. Prolonged use in children may affect growth and adrenal function. The use of tetracycline antibiotics, including oxytetracycline, is generally avoided in children under 8 years of age due to the risk of permanent tooth discoloration, although this concern is largely relevant to systemic administration rather than topical use.
How Does Addicort Interact with Other Drugs?
Since Addicort is applied topically and systemic absorption is generally low when used correctly, the risk of significant drug-drug interactions is considerably lower than with oral medications. However, several types of interactions are clinically relevant and should be considered by prescribers and patients.
The combination of multiple topical agents on the same area of skin can lead to additive effects, altered absorption profiles, and increased risk of adverse reactions. For this reason, it is important to inform your healthcare provider about all topical products you are currently using, including over-the-counter creams, cosmetics, and moisturizers.
Major Interactions
| Interacting Drug / Class | Type | Clinical Effect | Recommendation |
|---|---|---|---|
| Other topical corticosteroids | Additive | Increased risk of skin atrophy, adrenal suppression, and other corticosteroid-related side effects | Avoid concurrent use on the same area; use on different body sites if necessary |
| Topical retinoids (tretinoin, adapalene) | Potentiating | Increased skin irritation, dryness, and potential for increased corticosteroid absorption through compromised skin barrier | Do not apply to the same area simultaneously; separate application times if both are needed |
| Other topical antibiotics | Additive / Antagonistic | May increase antibiotic resistance risk; some combinations may be antagonistic | Avoid layering multiple topical antibiotics; consult prescriber for appropriate regimen |
Minor Interactions
| Interacting Drug / Class | Type | Clinical Effect | Recommendation |
|---|---|---|---|
| Topical antifungals | Pharmacological | The corticosteroid component may mask symptoms of fungal infection, potentially complicating diagnosis | Avoid concurrent use unless specifically directed by a dermatologist |
| Occlusive emollients / moisturizers | Pharmacokinetic | Heavy emollients may increase corticosteroid absorption by creating a semi-occlusive environment | Apply emollients at least 30 minutes before or after Addicort application |
| Skin-exfoliating products (AHAs, BHAs) | Potentiating | Compromised skin barrier may increase systemic absorption of both active ingredients | Discontinue exfoliating products during Addicort treatment |
If you are using Addicort on large areas of skin, under occlusive dressings, or for prolonged periods, systemic absorption may be sufficient to interact with oral medications. In particular, patients taking systemic corticosteroids, immunosuppressants, or medications metabolized by the same hepatic enzymes should inform their healthcare provider about their use of Addicort.
What Is the Correct Dosage of Addicort?
The correct dosage of Addicort depends on the severity and extent of the skin condition being treated, the location on the body, and individual patient factors. Your prescriber will provide personalized instructions based on your specific situation. The following guidelines represent standard dosing recommendations based on clinical practice and product information.
Adults
Standard Adult Dosage
Apply a thin layer of Addicort cream to the affected area 2–3 times daily. Gently rub the cream into the skin until it is absorbed. Wash and dry your hands before and after application (unless the hands are the treatment area). Treatment should be continued until the condition has resolved, but should not usually exceed 7–14 days. If symptoms persist beyond 7 days, consult your healthcare provider for reassessment.
The amount of cream needed depends on the size of the area to be treated. The fingertip unit (FTU) method provides a practical guide: one fingertip unit (a strip of cream from the tip to the first crease of the index finger, approximately 0.5 g) is sufficient to cover an area equivalent to two flat adult hands. For reference, typical amounts needed for different body regions include approximately 1 FTU for the face or neck, 3 FTUs for one arm, and 6 FTUs for one leg.
Children
Pediatric Dosage (Under Medical Supervision)
Addicort should only be used in children under the direct supervision of a healthcare provider. If prescribed, apply a thin layer to the affected area 1–2 times daily for the shortest duration possible, typically no more than 5–7 days. Use the minimum amount necessary to control symptoms. Children have a higher skin surface area-to-body weight ratio, increasing the risk of systemic absorption. Addicort is generally not recommended for children under 2 years of age without specialist consultation.
Elderly
Elderly Patients
Elderly patients may use Addicort at the standard adult dosage (2–3 times daily). However, elderly skin is typically thinner and more fragile, increasing susceptibility to corticosteroid-induced skin atrophy and bruising. Healthcare providers may opt for a shorter treatment course or less frequent application. Monitor for signs of skin thinning, especially on areas with already thin skin such as the forearms and shins.
Missed Dose
If you forget to apply Addicort at the scheduled time, apply it as soon as you remember. If it is almost time for the next application, skip the missed dose and continue with your regular schedule. Do not apply a double amount to make up for a missed application, as this increases the risk of local side effects without providing additional therapeutic benefit.
Overdose
Acute overdose from topical application is extremely unlikely. However, prolonged overuse or application to excessively large areas of skin can lead to systemic effects from both components. Signs of corticosteroid overexposure may include Cushing’s syndrome features (moon face, weight gain, high blood sugar, hypertension), adrenal suppression, and significant skin changes (atrophy, striae, telangiectasia). If you suspect overuse or experience any of these symptoms, discontinue the cream and contact your healthcare provider.
In the event of accidental oral ingestion (particularly relevant if children access the product), seek medical attention or contact a poison control center. While topical corticosteroid formulations are unlikely to cause serious acute toxicity if ingested once, medical evaluation is still recommended.
What Are the Side Effects of Addicort?
Like all medicines, Addicort can cause side effects, although not everybody experiences them. Most side effects from topical corticosteroid-antibiotic combinations are local (occurring at the application site) and are related to the duration of treatment. Short-term use according to the recommended guidelines carries a low risk of significant side effects, while prolonged or inappropriate use substantially increases the risk.
The side effects listed below are organized by frequency category according to international pharmacovigilance standards. If you experience any side effects not listed here, or if any listed side effects become severe, contact your healthcare provider or pharmacist.
Common
May affect up to 1 in 10 patients
- Burning or stinging sensation at the application site (usually temporary, resolves within minutes)
- Skin dryness in the treated area
- Mild itching (pruritus) at the application site
- Skin irritation or redness that may briefly worsen before improving
- Folliculitis (inflammation of hair follicles) in the treated area
Uncommon
May affect up to 1 in 100 patients
- Skin atrophy (thinning of the skin), particularly with prolonged use
- Striae (stretch marks), especially on the thighs, abdomen, and armpits
- Telangiectasia (visible small blood vessels on the skin surface)
- Hypopigmentation (lightening of the skin) in the treated area
- Contact allergic dermatitis (allergic reaction to one of the components)
- Acneiform eruptions (acne-like breakouts)
- Perioral dermatitis (rash around the mouth) with facial use
Rare
May affect up to 1 in 1,000 patients
- Adrenal suppression (with extensive or prolonged use), which may manifest as fatigue, weakness, and dizziness
- Cushing’s syndrome features (with chronic overuse on large areas), including moon face and weight gain
- Secondary fungal infection (candidiasis or dermatophyte infection) due to immunosuppressive effect of the corticosteroid
- Delayed wound healing
- Purpura (easy bruising) in the treated area
- Photosensitivity reactions (increased sensitivity to sunlight from the tetracycline component)
- Hypertrichosis (increased hair growth) at the application site
Seek medical attention right away if you experience signs of a severe allergic reaction such as sudden swelling of the face, lips, or throat, difficulty breathing, or a widespread rash with blistering. Also contact your doctor promptly if you notice signs of worsening infection (increased redness, warmth, swelling, pus), significant skin changes (deep stretch marks, very thin or fragile skin), or symptoms suggesting adrenal suppression (persistent fatigue, muscle weakness, nausea, dizziness).
It is important to understand that the risk of side effects is closely related to how Addicort is used. Following the prescribed dosage and duration, avoiding application to large areas, and not using occlusive dressings all help minimize the risk. The corticosteroid-related side effects (skin atrophy, striae, telangiectasia) are largely associated with prolonged use beyond the recommended treatment period and are more common on thin-skinned areas such as the face, groin, and armpits.
If side effects do occur, many local effects (such as skin atrophy) can be reversible if the medication is discontinued promptly. However, striae (stretch marks) are typically permanent once they develop. This underscores the importance of adhering to the recommended treatment duration and having regular follow-up with your healthcare provider.
How Should You Store Addicort?
Proper storage of Addicort cream is essential to maintain the stability, efficacy, and safety of both active ingredients throughout the product’s shelf life. Topical formulations can be affected by temperature extremes, light exposure, and microbial contamination if not stored correctly.
Follow these storage guidelines:
- Temperature: Store at or below 25°C (77°F). Do not store in direct sunlight or near sources of heat. Avoid leaving the tube in a parked car or in a bathroom where temperatures can fluctuate.
- Protection from light: Keep the tube in the original outer carton when not in use, as the tetracycline component is light-sensitive and may degrade with prolonged light exposure.
- Do not freeze: Freezing can alter the cream’s formulation, affecting its consistency and the distribution of active ingredients.
- Keep the tube tightly closed: Replace the cap securely after each use to prevent contamination and drying out of the cream.
- Child safety: Store out of the sight and reach of children. The cream could be harmful if ingested, particularly to young children.
- Expiry date: Do not use after the expiry date (EXP) printed on the tube and carton. The expiry date refers to the last day of that month.
- Once-opened shelf life: After first opening, use within the timeframe specified on the packaging (typically 3–6 months). Discard any remaining cream beyond this period.
Do not dispose of Addicort cream in household waste or via wastewater. Ask your pharmacist about proper disposal methods in accordance with local regulations. Proper disposal helps protect the environment, particularly aquatic ecosystems that may be affected by pharmaceutical residues.
What Does Addicort Contain?
Active Ingredients
| Ingredient | Concentration | Role | Pharmacological Class |
|---|---|---|---|
| Oxytetracycline hydrochloride | 20 mg/g | Antibacterial agent | Tetracycline antibiotic |
| Triamcinolone acetonide | 1 mg/g (0.1%) | Anti-inflammatory, antipruritic | Moderate-potency corticosteroid |
Inactive Ingredients (Excipients)
The cream base contains various excipients that serve as the vehicle for delivering the active ingredients to the skin. Common excipients in topical cream formulations of this type include emulsifying agents, preservatives, and moisturizing components. The exact excipient list may vary between manufacturers and should be checked on the product packaging if you have known sensitivities to any specific inactive ingredients.
Patients with known allergies to any pharmaceutical excipients should review the full ingredient list on the product leaflet or consult their pharmacist before use. Of particular note, some cream formulations may contain ingredients such as cetyl alcohol, stearyl alcohol, or parabens that can cause contact sensitization in susceptible individuals.
Triamcinolone acetonide at 0.1% concentration is classified as a moderate-potency (Group III-IV) topical corticosteroid according to international classification systems. This places it in the mid-range of topical corticosteroid potency, making it suitable for most inflammatory skin conditions while carrying a lower risk of severe corticosteroid-related side effects compared to high-potency preparations. For context, mild corticosteroids include hydrocortisone 1%, while potent corticosteroids include betamethasone valerate 0.1%.
Frequently Asked Questions About Addicort
Addicort cream is a prescription topical medication used to treat inflamed skin conditions where bacterial infection is present or suspected. It combines oxytetracycline (an antibiotic) with triamcinolone acetonide (a corticosteroid) to simultaneously fight infection and reduce inflammation, itching, and redness. Common uses include infected eczema, infected contact dermatitis, infected insect bites, and other inflammatory skin conditions complicated by bacterial infection.
Apply a thin layer of Addicort cream to the affected area 2–3 times daily, or as directed by your doctor. Wash and dry your hands before and after application. Gently rub the cream into the skin until it is absorbed. Do not cover the treated area with airtight dressings (occlusive bandages) unless specifically instructed by your physician. Treatment duration is usually limited to 7–14 days. Do not apply to the face, groin, or armpits for prolonged periods.
Addicort cream should generally be avoided on the face due to the corticosteroid component (triamcinolone acetonide), which can cause skin thinning, telangiectasia (visible blood vessels), and perioral dermatitis when used on facial skin. The face is particularly susceptible to corticosteroid side effects because facial skin is thinner and more permeable than skin on most other body parts. If facial use is necessary, it should be for the shortest time possible (no more than 5–7 days) and only under close medical supervision.
Common side effects of Addicort cream include a burning or stinging sensation at the application site, skin dryness, itching, and mild irritation. These are usually temporary and resolve on their own. With prolonged use, more significant side effects may occur including skin thinning (atrophy), stretch marks (striae), easy bruising, and increased susceptibility to skin infections. If you notice any unusual skin changes, discontinue use and consult your healthcare provider.
Addicort cream should be used during pregnancy only when clearly necessary and under medical supervision. Topical corticosteroids have not been shown to be teratogenic in human studies when used in small amounts for short periods, but animal studies with high doses of triamcinolone have shown adverse effects. The tetracycline component (oxytetracycline) is generally contraindicated during pregnancy as systemic tetracyclines can affect fetal bone and tooth development, although topical absorption is typically minimal. Always discuss the risks and benefits with your doctor before using Addicort during pregnancy.
Addicort cream is intended for short-term use, typically no longer than 7–14 days. Prolonged use increases the risk of corticosteroid-related side effects such as skin atrophy, striae, telangiectasia, and potential adrenal suppression. Additionally, extended use of the antibiotic component may promote bacterial resistance. If your symptoms have not improved within 7 days, consult your doctor for reassessment. Never use topical corticosteroid-antibiotic combinations continuously without ongoing medical supervision.
References
All information in this article is based on international medical guidelines and peer-reviewed research. iMedic follows the GRADE evidence framework and sources information exclusively from recognized medical authorities.
- British Association of Dermatologists (BAD). Guidelines for the management of atopic eczema. British Journal of Dermatology. 2024. BAD Clinical Guidelines
- National Institute for Health and Care Excellence (NICE). Eczema – atopic: Topical corticosteroids. NICE Clinical Knowledge Summaries. 2024. NICE CKS
- European Medicines Agency (EMA). Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis and eczema. 2023. EMA Guidelines
- World Health Organization (WHO). Model List of Essential Medicines – 23rd List. 2023. WHO Essential Medicines
- Rathi SK, D'Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian Journal of Dermatology. 2012;57(4):251-259. doi:10.4103/0019-5154.97655
- Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatology Online Journal. 2014;5(4):416-425. doi:10.4103/2229-5178.142483
- Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis. Journal of the American Academy of Dermatology. 2023;89(4):e135-e148. AAD Guidelines
- WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). Critically Important Antimicrobials for Human Medicine. 6th Revision. 2019. WHO AGISAR
- British National Formulary (BNF). Topical corticosteroids: Potency ranking and prescribing guidance. 2024. BNF
- Wollenberg A, et al. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy. Journal of the European Academy of Dermatology and Venereology. 2022;36(9):1409-1431. doi:10.1111/jdv.18345
Editorial Team
This article has been written and reviewed by our medical editorial team, comprising licensed physicians with specialist training in dermatology and clinical pharmacology. All medical claims are evidence-based and supported by peer-reviewed research and international clinical guidelines.
Medical Writing Team
Dermatology & Clinical Pharmacology Specialists
Licensed physicians with expertise in topical therapeutics, skin pharmacology, and evidence-based dermatology. Members of international dermatological societies.
Medical Review Board
Independent Peer Review Panel
Board-certified dermatologists and pharmacologists who independently verify all medical claims against current guidelines (BAD, AAD, NICE, EMA) and the GRADE evidence framework.
All content on iMedic is created following strict editorial standards. We use only peer-reviewed sources, international guidelines, and evidence-based medicine principles. Our content is free from pharmaceutical industry influence. Read our full editorial standards.